Predictive Oncology’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Predictive Oncology is an AI-based drug discovery platform that provides medicinal data analytics for the pharmaceutical industry. Read more

CEO Avatar

Chairman & CEO

Carl Schwartz

CEO Approval Rating

90/100

Founded:

2002

Status:

PublicNASDAQPOAI

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ReWalk is a top competitor of Predictive Oncology. ReWalk was founded in Marlborough, Massachusetts} in 2001. ReWalk competes in the Technology Hardware industry. Compared to Predictive Oncology, ReWalk generates $3.2M more revenue.

ReShape Lifesciences is Predictive Oncology's #2 competitor. ReShape Lifesciences is headquartered in San Clemente, California, and was founded in 2002. ReShape Lifesciences operates in the Health Care Equipment industry. ReShape Lifesciences generates 894% the revenue of Predictive Oncology.

Second Sight has been one of Predictive Oncology's top competitors. Second Sight is a Public company that was founded in 1998 in Sylmar, California. Second Sight operates in the Health Care Equipment industry. Compared to Predictive Oncology, Second Sight has 5 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Predictive Oncology?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.3M

Predictive Oncology's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 4.8M. Over the last four quarters, Predictive Oncology's revenue has decreased by 65%. Specifically, in Q2 2020's revenue was $ < 1M; in Q1 2020, it was $ < 1M; in Q4 2019, it was $ < 1M; in Q3 2019, Predictive Oncology's revenue was $ < 1M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Jun 2020

Source »
undisclosed
-

These are all the companies that Predictive Oncology has acquired. Predictive Oncology's latest acquisition was in Jun 2020.

Predictive Oncology Funding History

$4M

Since Predictive Oncology was founded in 2002, it has participated in 2 rounds of funding. In total Predictive Oncology has raised $4.0M. Predictive Oncology's last funding round was on Apr 2020 for a total of $541.9K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$541.9K

Park State Bank

Private Placement
Mar 2020
$3.5M
-

Total Funding: $4M

Since Predictive Oncology was founded in 2002, it has participated in 2 rounds of funding. In total Predictive Oncology has raised $4.0M. Predictive Oncology's last funding round was on Apr 2020 for a total of $541.9K

Investments

No recent investments found related to Predictive Oncology

Predictive Oncology News

August 18, 2020MarketScreener

Predictive Oncology's Skyline Medical Sells 8 STREAMWAY Systems to a Large University Hospital Organization in Virginia; 13 STREAMWAY Systems Sold Halfway Into Q3 2020

(marketscreener.com) EAGAN, Minn., Aug. 18, 2020 -- Predictive Oncology , a knowledge-driven company ... See more »
August 14, 2020Medical Device News Magazine

'Can We Cure Cancer with Artificial Intelligence?' Predictive Oncology Announces DojoLIVE! Interview with Helomics CIO Mark Collins

The broadcast, titled 'Can We Cure Cancer With Artificial Intelligence?', is available for on-demand ... See more »
July 7, 2020BioSpace

Predictive Oncology Completes Acquisition of Quantitative MedicineAcquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelli... See more »
June 29, 2020MarketScreener

Predictive Oncology Inc. Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants

(marketscreener.com) MINNEAPOLIS, June 29, 2020 -- Predictive Oncology Inc. , a knowledge-driven comp... See more »
June 8, 2020BioSpace

Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business UpdateCancerQuest 2020 Study on Schedule for Completion in Q2 2020

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelli... See more »

Predictive Oncology Press Releases

August 26, 2020Network Newswire

POAI) Exclusive Resources Provide Personal Profiling, Tools to Improve Patient Outcomes - NetworkNewsWire

POAI, Helomics builds AI-driven models that predict drug response, patient outcome Company tests pati... See more »
August 20, 2020GlobalNewswire

Soluble Biotech Announces First Contract with a Major Pharmaceutical Company for Protein Expression and Solubility Studies

EAGAN, Minn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-drive... See more »
August 3, 2020Network Newswire

POAI)'s TumorGenesis Presents at Precision in Drug Discovery & Preclinical Virtual Summit - NetworkNewsWire

TumorGenesis president Richard Gabriel selected to feature as keynote presenter at inaugural Drug Dis... See more »
July 30, 2020Network Newswire

POAI) Subsidiary Announces First Commercial Sale of Unique Ovarian-Cancer-Cell Media - NetworkNewsWire

POAI's TumorGenesis inks deal with top-rated medical university in New England Predictive's proprieta... See more »
June 4, 2020Network Newswire

POAI) CEO Discusses Acquisitions, Exclusive Database of Historical Tumor Data in Recent Interview - NetworkNewsWire

POAI boasts unique historical database documenting actual drug responses of tumors - the largest in t... See more »
June 2, 2020Network Newswire

POAI) Subsidiary a 'Major Asset' in Growing Precision Medicine Space - NetworkNewsWire

POAI addresses pressing need for a multi-omic approach in field of precision medicine Global precisio... See more »

Headquarters

2915 Commers Drive Suite 900

Eagan, Minnesota55121

651-389-4806

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Predictive Oncology is an AI-based drug discovery platform that provides medicinal data analytics for the pharmaceutical industry. Predictive Oncology was founded in 2002. Predictive Oncology's headquarters is located in Eagan, Minnesota, USA 55121. I...

CEO

Predictive Oncology's Chairman & CEO, Carl Schwartz, currently has an approval rating of 90%. Predictive Oncology's primary competitors are ReWalk, ReShape Lifesciences & Second Sight.

Website

predictive-oncology.com

Frequently Asked Questions about Predictive Oncology

  1. When was Predictive Oncology founded?

    Predictive Oncology was founded in 2002
  2. Who is Predictive Oncology's CEO?

    Predictive Oncology's CEO is Carl Schwartz
  3. How much revenue does Predictive Oncology generate?

    Predictive Oncology generates $1.3M in revenue
  4. How much funding does Predictive Oncology have?

    Predictive Oncology has historically raised $4M in funding
  1. Where is Predictive Oncology's headquarters?

    Predictive Oncology's headquarters is in Eagan Minnesota, USA
  2. How many employees does Predictive Oncology have?

    Predictive Oncology has 29 employees
  3. What sector does Predictive Oncology operate in?

    Predictive Oncology is in Biotechnology
  4. Who are Predictive Oncology's competitors?

    Predictive Oncology's top competitors are ReWalk, ReShape Lifesciences, Second Sight